These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21340381)

  • 1. Epsilon-aminocaproic acid influence in postoperative [corrected] bleeding and hemotransfusion [corrected] in mitral valve surgery.
    Benfatti RÁ; Carli AF; Silva GV; Dias AE; Goldiano JA; Pontes JC
    Rev Bras Cir Cardiovasc; 2010; 25(4):510-5. PubMed ID: 21340381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial.
    Verma K; Errico T; Diefenbach C; Hoelscher C; Peters A; Dryer J; Huncke T; Boenigk K; Lonner BS
    J Bone Joint Surg Am; 2014 May; 96(10):e80. PubMed ID: 24875032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery.
    Breda JR; Gurian DB; Breda AS; Meneghine A; Freitas AC; Matos LL; Abreu LC; Pires AC
    Rev Bras Cir Cardiovasc; 2009; 24(3):341-5. PubMed ID: 20011881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood loss and transfusion requirements with epsilon-aminocaproic acid use during cranial vault reconstruction surgery.
    Thompson ME; Saadeh C; Watkins P; Nagy L; Demke J
    J Clin Anesth; 2017 Feb; 36():153-157. PubMed ID: 28183556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass.
    Gurian DB; Meneghini A; Abreu LC; Murad N; Matos LL; Pires AC; Valenti VE; Breda JR
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):615-20. PubMed ID: 23434921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization.
    Hardy JF; Bélisle S; Dupont C; Harel F; Robitaille D; Roy M; Gagnon L
    Ann Thorac Surg; 1998 Feb; 65(2):371-6. PubMed ID: 9485231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Safety of Epsilon-Aminocaproic Acid for Perioperative Blood Management in Spinal Fusion Surgery: A Systematic Review and Meta-Analysis.
    Li S; Xing F; Cen Y; Zhang Z
    World Neurosurg; 2021 Dec; 156():12-21. PubMed ID: 34478888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
    Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid.
    Karski JM; Teasdale SJ; Norman PH; Carroll JA; Weisel RD; Glynn MF
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):431-5. PubMed ID: 8104526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
    Kikura M; Levy JH; Tanaka KA; Ramsay JG
    J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
    Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
    J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different dosage regimes of epsilon aminocaproic acid on blood loss in children undergoing craniosynostosis surgery.
    Nguyen TT; Lam HV; Austin TM; Stricker P; Tunceroglu H; Schoenecker J
    Paediatr Anaesth; 2019 Aug; 29(8):858-864. PubMed ID: 31141266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
    Li G; Sun TW; Luo G; Zhang C
    Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
    Hobbs JC; Welsby IJ; Green CL; Dhakal IB; Wellman SS
    J Arthroplasty; 2018 Jan; 33(1):55-60. PubMed ID: 28939033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
    Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery.
    Williams GD; Bratton SL; Riley EC; Ramamoorthy C
    J Cardiothorac Vasc Anesth; 1999 Jun; 13(3):304-8. PubMed ID: 10392682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.